BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19110449)

  • 1. The novel hormone INSL3 is expressed in human testicular Leydig cell tumors: a clinical and immunohistochemical study.
    Rossato M; Tavolini IM; Calcagno A; Gardiman M; Dal Moro F; Artibani W
    Urol Oncol; 2011; 29(1):33-7. PubMed ID: 19110449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the insulin-like peptide 3 (INSL3) hormone-receptor (LGR8) system in the testis.
    Anand-Ivell RJ; Relan V; Balvers M; Coiffec-Dorval I; Fritsch M; Bathgate RA; Ivell R
    Biol Reprod; 2006 May; 74(5):945-53. PubMed ID: 16467492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INSL3 Expression in Leydig Cell Hyperplasia and Leydig Cell Tumors.
    Lakis NS; Lombardo KA; Mangray S; Netto GJ; Salles D; Matoso A
    Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):203-209. PubMed ID: 29084059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human testicular insulin-like factor 3: in relation to development, reproductive hormones and andrological disorders.
    Bay K; Andersson AM
    Int J Androl; 2011 Apr; 34(2):97-109. PubMed ID: 20550598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression patterns of DLK1 and INSL3 identify stages of Leydig cell differentiation during normal development and in testicular pathologies, including testicular cancer and Klinefelter syndrome.
    Lottrup G; Nielsen JE; Maroun LL; Møller LM; Yassin M; Leffers H; Skakkebæk NE; Rajpert-De Meyts E
    Hum Reprod; 2014 Aug; 29(8):1637-50. PubMed ID: 24908673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like factor 3: a novel circulating hormone of testicular origin in humans.
    Ferlin A; Foresta C
    Ann N Y Acad Sci; 2005 May; 1041():497-505. PubMed ID: 15956751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The orphan nuclear receptor NR4A1 regulates insulin-like 3 gene transcription in Leydig cells.
    Robert NM; Martin LJ; Tremblay JJ
    Biol Reprod; 2006 Feb; 74(2):322-30. PubMed ID: 16237153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel circulating hormone of testis origin in humans.
    Foresta C; Bettella A; Vinanzi C; Dabrilli P; Meriggiola MC; Garolla A; Ferlin A
    J Clin Endocrinol Metab; 2004 Dec; 89(12):5952-8. PubMed ID: 15579743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Leydig cell tumor of the testis].
    Ponce de León Roca J; Algaba Arrea F; Bassas Arnau L; Villavicencio Mavrich H
    Arch Esp Urol; 2000; 53(6):453-8. PubMed ID: 11002512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical evaluation of GATA-4 in canine testicular tumors.
    Ramos-Vara JA; Miller MA
    Vet Pathol; 2009 Sep; 46(5):893-6. PubMed ID: 19429994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abundance of DLK1, differential expression of CYP11B1, CYP21A2 and MC2R, and lack of INSL3 distinguish testicular adrenal rest tumours from Leydig cell tumours.
    Lottrup G; Nielsen JE; Skakkebæk NE; Juul A; Rajpert-De Meyts E
    Eur J Endocrinol; 2015 Apr; 172(4):491-9. PubMed ID: 25609776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like factor 3: where are we now?
    Ivell R; Hartung S; Anand-Ivell R
    Ann N Y Acad Sci; 2005 May; 1041():486-96. PubMed ID: 15956750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibin A is a sensitive and specific marker for testicular sex cord-stromal tumors.
    Iczkowski KA; Bostwick DG; Roche PC; Cheville JC
    Mod Pathol; 1998 Aug; 11(8):774-9. PubMed ID: 9720507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leydig cell tumor: a report of two cases with unusual presentation.
    Sengupta S; Chatterjee U; Sarkar K; Chatterjee S; Kundu A
    Indian J Pathol Microbiol; 2010; 53(4):796-8. PubMed ID: 21045421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAGE-1 and MAGE-3 tumor rejection antigens in human germ cell tumors.
    Cheville JC; Roche PC
    Mod Pathol; 1999 Oct; 12(10):974-8. PubMed ID: 10530563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant Leydig-cell tumor of the testis diagnosed by fine-needle aspiration using ThinPrep technique.
    Valeri RM; Kotakidou R; Michalakis K; Andreadis C; Kousi-Koliakou K; Destouni C
    Diagn Cytopathol; 2011 May; 39(5):368-72. PubMed ID: 20730900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Origin and evolution of somatic cell testicular tumours in transgenic mice.
    Quintana S; Venara M; Rey R; di Clemente N; Chemes HE
    J Pathol; 2010 Aug; 221(4):443-51. PubMed ID: 20593483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative molecular analysis of testicular Leydig cell tumors demonstrates distinct subsets of neoplasms with aggressive histopathologic features.
    Rizzo NM; Sholl LM; Idrees MT; Cheville JC; Gupta S; Cornejo KM; Miyamoto H; Hirsch MS; Collins K; Acosta AM
    Mod Pathol; 2021 Oct; 34(10):1935-1946. PubMed ID: 34103665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An in-depth look at Leydig cell tumor of the testis.
    Al-Agha OM; Axiotis CA
    Arch Pathol Lab Med; 2007 Feb; 131(2):311-7. PubMed ID: 17284120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of nuclear receptors in INSL3 gene transcription in Leydig cells.
    Tremblay JJ; Robert NM
    Ann N Y Acad Sci; 2005 Dec; 1061():183-9. PubMed ID: 16467267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.